Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alberto Fumagalli
Correction: Everolimus (EVE) and Exemestane (EXE) in Patients With Advanced Breast Cancer Aged ≥ 65 Years: New Lessons for Clinical Practice From the EVA Study
Oncotarget
Oncology
Correction 2: Everolimus (EVE) and Exemestane (EXE) in Patients With Advanced Breast Cancer Aged ≥ 65 Years: New Lessons for Clinical Practice From the EVA Study
Oncotarget
Oncology
Related publications
Costs of HER 2 Negative, Hormonal Receptor Positive, Metastatic Breast Cancer (MBC-HR+) Treated With Everolimus (EVE) + Exemestane (EXE) in the Brazilian Private System (BPS): A Real World (RW) and Published Literature Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Exemestane for Locally Advanced Breast Cancer: A Case Report
The Internet Journal of Surgery
Imatinib and Everolimus in Patients With Progressing Advanced Chordoma: A Phase 2 Clinical Study
Cancer
Cancer Research
Oncology
Clinical and Audiologic Characteristics of Tinnitus in Subjects Aged <65 and ≥65 Years
Journal of International Advanced Otology
Medicine
Otorhinolaryngology
Correction To: Neutropenia Management With Palbociclib in Japanese Patients With Advanced Breast Cancer
Breast Cancer
Nuclear Medicine
Radiology
Pharmacology
Oncology
Imaging
Medicine
Hormone Treatment Without Surgery for Patients Aged 75 Years or Older With Operable Breast Cancer
Indian Journal of Surgical Oncology
Surgery
Oncology
Characteristics of the Gastric Cancer in the Aged(over 65 Years Old).
Japanese Journal of Geriatrics
Gerontology
Geriatrics
Clinical and Economic Analysis of Effectiveness of Everolimus in the Treatment of HR+, HER2- Advanced Breast Cancer in Russia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
